Loading clinical trials...
Loading clinical trials...
The main purposes of the AIDA protocol are to test the role of intermittent maintenance therapy with ATRA, standard maintenance chemotherapy with methotrexate and 6-mercaptopurine of both in PCR negat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
NCT06285890 · Acute Myeloid Leukemia
NCT06197672 · Acute Myeloid Leukemia
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT07400029 · Acute Lymphoblastic Leukemia
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
Department of Hematology - Middelheim Ziekenhuis
Antwerp
Department of Hematology - Klinikum Grosshadem - Ludwig Maxmilians
München
S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo
Alessandria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions